Lemon Verbena for Health & Longevity - Quick Reference Sheet

Lemon Verbena for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

A South American shrub whose leaf extract modestly lowers body weight, waist size and blood pressure, and raises protective cholesterol — mostly tested blended with hibiscus flower. Separate trials show better-rated sleep, less perceived stress, and less muscle damage after hard training. Safety looks quiet up to three months. Much of that evidence comes from the companies selling the ingredient. (Full Review)

Protocol

Standard sleep and stress protocol
400 mg daily
Leaf extract standardized to a minimum 24% verbascoside and 28% total phenylpropanoids, one to two hours before bed, for at least eight weeks
Standard metabolic protocol
500 mg daily
Lemon verbena and hibiscus flower blend, 20 to 30 minutes before breakfast, for 8 to 12 weeks alongside diet and walking
Standard exercise-recovery protocol
400 mg daily
Leaf extract, begun about ten days before a demanding training block or event and continued through the recovery period
Time to effect
Appetite & Weight
30 to 60 days
Appetite and weight effects appeared in this window
Sleep & Stress
4 weeks
Questionnaires separated from placebo in most trials; wrist movement-tracking changes by 45 days
Muscle Recovery
10 days
Effects present after ten days of loading

Benefits

Contraindications
  • Pregnancy and breastfeeding at any stage
  • Known allergy to Verbenaceae plants, or documented citral contact allergy
  • Diagnosed hypotension, or treated blood pressure below 100/60 mmHg
  • Chronic kidney disease stage 4 or worse (filtration rate below 30 mL/min/1.73 m²)
  • Under 18 (metabolic and sports indications)
  • Within seven days of scheduled surgery
Key Interactions
  • Blood-pressure medications (lisinopril, losartan, amlodipine, hydrochlorothiazide)
  • Sedating medications (diazepam, zolpidem, diphenhydramine, alcohol)
  • Blood thinners, theoretical (aspirin, clopidogrel, warfarin, apixaban)
  • Blood-sugar and appetite drugs (metformin, glipizide, semaglutide)
  • Blood-pressure-lowering supplements (hibiscus, beetroot nitrate, magnesium, garlic extract, omega-3 fatty acids)
  • Sedating botanicals (valerian, lemon balm, ashwagandha, kava, melatonin)
  • Iron supplements and iron-rich meals
  • Caloric restriction and endurance training

Risk & Side Effects

  • High: Additive blood-pressure lowering
  • Medium: Daytime sedation and reduced subjective energy; mild gastrointestinal discomfort; skin sensitization from the essential oil
  • Low: Blunting of exercise-training adaptations; reduced non-heme iron absorption; absence of long-term safety data
  • Speculative: Renal irritation with prolonged essential-oil use; altered sperm parameters

Monitoring

Marker Target Why
Seated blood pressure 110-120 / 70-80 mmHg Tracks the best-evidenced benefit and the main risk simultaneously
Body weight and waist circumference Waist below half of height Primary endpoint of the metabolic protocol
Body-fat percentage 10-20% men, 18-28% women Distinguishes fat loss from lean-mass loss during appetite suppression
Total cholesterol and HDL-C Total below 200 mg/dL; HDL-C above 60 mg/dL The pooled lipid effect acts on exactly these two fractions
Fasting glucose 75-85 mg/dL Pooled analysis found no glucose effect, so drift signals something else
Glycated hemoglobin Below 5.4% Confirms the absent glucose signal over three months rather than one morning
High-sensitivity CRP Below 0.5 mg/L The one inflammation marker that moved in a lemon verbena trial
ALT and AST ALT 10-26 U/L, AST 10-26 U/L Organ safety for a concentrated botanical with no long-term data
Creatinine and eGFR eGFR above 90 mL/min/1.73 m² Addresses the traditional renal-irritation caution and metabolite clearance
Ferritin 50-100 ng/mL men, 40-80 ng/mL women The iron-chelation risk is the one nutrient interaction with a real mechanism
Creatine kinase Below 200 U/L at rest Recovery-protocol endpoint; the marker two trials disagreed on
Morning cortisol 10-15 mcg/dL at 7-8 a.m. The proposed stress mechanism; fell 15.6% in one trial and not at all in another

Cadence: Blood pressure daily for the first four weeks, then weekly. Questionnaires, weight and waist repeat at 4 and 8 weeks. Bloods repeat at 12 weeks, then every 6 to 12 months on continued use.

Qualitative Assessment

  • Time taken to fall asleep, and number of night-time awakenings
  • Morning alertness on waking, and whether residual drowsiness appears
  • Daytime energy through the afternoon, which is the marker that moved unfavorably in the largest trial
  • Perceived stress and irritability under a constant workload
  • Hunger between meals and cravings in the evening
  • Muscle soreness 24 to 72 hours after a hard session